Iterum Therapeutics plc

(NASDAQ:ITRM)

Latest On Iterum Therapeutics plc (ITRM):

Date/Time Type Description Signal Details
2023-05-12 10:43 ESTNewsIterum Therapeutics Non-GAAP EPS of -$0.58N/A
2023-03-16 19:24 ESTNewsIterum Therapeutics Non-GAAP EPS of -$0.52 beats by $0.63N/A
2023-03-16 19:24 ESTNewsIterum Therapeutics plc (ITRM) Q4 2022 Earnings Call TranscriptN/A
2023-03-16 04:01 ESTNewsIterum Therapeutics Q4 2022 Earnings PreviewN/A
2022-12-15 11:13 ESTNewsIterum Therapeutics rises 21% on U.S. patent covering oral sulopenemN/A
2022-11-10 18:36 ESTNewsIterum Therapeutics Non-GAAP EPS of -$0.43 beats by $0.49N/A
2022-11-10 18:35 ESTNewsIterum Therapeutics plc (ITRM) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 18:35 ESTNewsIterum Therapeutics plc 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-10 01:41 ESTNewsIterum Therapeutics Q3 2022 Earnings PreviewN/A
2022-09-02 00:48 ESTNewsIterum Therapeutics regains Nasdaq compliance as price sclaes above $1N/A
2022-08-17 19:54 ESTNewsIterum Therapeutics stock slides on 1-for-15 reverse share splitN/A
2022-08-12 20:48 ESTNewsIterum Therapeutics Non-GAAP EPS of -$0.03 beats by $0.03N/A
2022-07-11 20:43 ESTNewsIterum jumps 64% as FDA agrees to Phase 3 trial for UTI candidateN/A
2022-05-13 17:48 ESTNewsIterum Therapeutics Non-GAAP EPS of -$0.03 beats by $0.01N/A
2022-03-30 03:06 ESTNewsIterum Therapeutics plc's (ITRM) CEO Corey Fishman on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-29 02:33 ESTNewsIterum Therapeutics GAAP EPS of -$0.02 beats by $0.02N/A
2022-03-29 02:32 ESTNewsIterum Therapeutics plc (ITRM) CEO Corey Fishman on Q4 2021 Results - Earnings Call TranscriptN/A
2021-11-12 23:05 ESTNewsIterum Therapeutics EPS beats by $0.01N/A
2021-11-12 23:05 ESTNewsIterum Therapeutics plc (ITRM) CEO Corey Fishman on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-14 19:58 ESTNewsWarning: ITRM is at high risk of performing badlyN/A
2021-10-06 10:24 ESTNewsITRM is at high risk of performing badlyN/A
2021-09-28 18:27 ESTNewsIterum provides update on Type A meeting with the U.S. FDA on oral sulopenem NDAN/A
2021-09-27 19:46 ESTNewsWarning: ITRM has been downgraded to Very BearishN/A
2021-09-23 05:29 ESTNewsWarning: ITRM has been downgraded to Very Bearish.N/A
2021-08-13 15:23 ESTNewsIterum Therapeutics EPS beats by $0.02N/A
2021-08-13 15:22 ESTNewsIterum Therapeutics plc (ITRM) CEO Corey Fishman on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-12 19:05 ESTNewsIterum Therapeutics Q2 2021 Earnings PreviewN/A
2021-07-29 20:31 ESTNewsDays after Complete Response Letter for sulopenem, Iterum stages major comebackN/A
2021-07-26 17:55 ESTNewsIterum plunges after announcing FDA’s Complete Response Letter for sulopenemN/A
2021-07-26 17:54 ESTNewsTyme Technologies, Xenetic Biosciences leads healthcare gainers; ATI Physical Therapy, Iterum Therapeutic among major losersN/A
2021-07-21 12:47 ESTNewsIterum Therapeutics shares rise after sulopenem NDA updateN/A
2021-07-21 12:47 ESTNewsIterum keeps rising even as RBC analyst cautions, Premier hurt by Barclays’ double downgrade; and more in today’s analyst actionN/A
2021-07-21 12:28 ESTNewsIterum stock slumps 40% after FDA identifies deficiencies in sulopenem NDAN/A
2021-07-21 12:27 ESTNewsDespite Risks Around Regulatory Approval, Iterum Therapeutics Rates A Speculative BuyN/A
2021-07-21 12:27 ESTNewsH.C. Wainwright still bullish on Iterum despite Friday selloffN/A
2021-07-21 12:25 ESTNewsAlector leads weekly healthcare gainers; gene-editing stocks fall after Intellia-driven rallyN/A
2021-04-29 15:10 ESTNewsIterum: Failed Trials, Delayed NDAs, And DilutionsN/A
2021-04-29 15:09 ESTNewsIterum Therapeutics: Delayed Review Of Its NDA For Sulopenem, But Upside Still ExistsN/A
2021-03-18 09:06 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 21:04 ESTAnalyst RatingThe Analyst Target Price has increased from $1.83 to $2.25.Buy
2021-03-17 02:23 ESTNewsLilly’s Alzheimer's data fail to impress Wall Street; Savara climbs on Oppenheimer initiation in pre-market analyst actionN/A
2021-03-16 21:10 ESTEarnings EstimateAn EPS average of -$0.31 is estimated for the 2022 year.Sell
2021-03-16 21:10 ESTEarnings EstimateAn EPS average of -$0.07 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-16 21:10 ESTAnalyst RatingThe Analyst Target Price has increased from $1.5 to $1.83.Buy
2021-03-14 08:56 ESTFinancialsCompany financials have been released.Neutral
2021-03-13 02:26 ESTNewsIterum Therapeutics EPS beats by $0.06N/A
2021-03-13 02:26 ESTNewsIterum Therapeutics plc (ITRM) CEO Corey Fishman on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-12 20:08 ESTNewsIterum Therapeutics: Sulopenem Approval Decision In July Is Make Or BreakN/A
2021-02-10 13:24 ESTNewsTLRY, GLUU, ABEO and TYME among premarket gainersN/A
2021-02-10 13:23 ESTNewsIterum Therapeutics slips 6% on launch of direct offeringN/A

About Iterum Therapeutics plc (ITRM):

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The company is developing sulopenem, a novel penem anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was founded in 2015 and is headquartered in Dublin, Ireland.

ITRM Quotes by TradingView

See Advanced Chart

General

  • Name Iterum Therapeutics plc
  • Symbol ITRM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 44
  • Fiscal Year EndDecember
  • IPO Date2018-05-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.iterumtx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 1349.79
  • Enterprise Value Revenue 105.22
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.34
  • Next Year EPS Estimate -$0.36
  • Next Quarter EPS Estimate -$0.19
  • Return on Assets -69%
  • Earnings Per Share -$7.05
  • Revenue Per Share $0
  • Gross Profit 37000
  • Quarterly Earnings Growth -100%
View More

Highlights

  • Market Capitalization 291.19 million
  • EBITDA -96628000
  • Analyst Target Price $2.25
  • Book Value Per Share $1.71
View More

Share Statistics

  • Shares Outstanding 176.48 million
  • Shares Float 175.79 million
  • % Held by Insiders 115%
  • % Held by Institutions 34.21%
  • Shares Short 3.63 million
  • Shares Short Prior Month 3.8 million
  • Short Ratio 0.08
  • Short % of Float 3%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.4
  • 52 Week High $4.7
  • 52 Week Low $0.45
  • 50 Day Moving Average 1.72
  • 200 Day Moving Average 1.07
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Iterum Therapeutics plc (ITRM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Iterum Therapeutics plc (ITRM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-12$N/A-$0.11-$0.1735.29%
2020-09-302020-11-16$N/A-$0.34-$0.7956.96%
2020-06-302020-08-06$N/A-$0.56-$0.9842.56%
2020-03-312020-05-14$N/A-$0.90-$1.5039.8%
2019-12-312020-03-12$N/A-$1.59-$1.706.29%
2019-09-302019-11-12$N/A-$2.15-$1.71-25.97%
2019-06-302019-08-14$N/A-$1.93-$1.55-24.25%
2019-03-312019-05-14$37000-$1.44-$1.40-3.23%
2018-12-312019-03-25$239000-$1.19-$2.2346.64%
2018-09-302018-11-14$254000-$1.24-$2.1742.73%
2018-06-302018-08-14$185000-$1.53-$1.29-18.6%
2018-03-312018-05-25$191000-$1.60

Iterum Therapeutics plc (ITRM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A 9.74 million 20.88 million
Income Before Tax N/A N/A N/A -15.98 million -23.59 million
Selling General Administrative N/A N/A N/A 3.15 million 2.3 million
Gross Profit N/A N/A N/A N/A N/A
Ebit N/A N/A N/A -13.34 million -23.18 million
Operating Income N/A N/A N/A -12.89 million -23.18 million
Income Tax Expense 24000 420000 178000 N/A 49000
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A -489000 -414000
Net Income From Continuing Operations N/A N/A N/A -16.1 million -23.64 million
Net Income Applicable to Common Shares -11.19 million -12.2 million -12.52 million N/A -23.64 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A -2000 N/A N/A 25000
Change to Liabilities -1.84 million N/A N/A N/A 4.37 million
Total Cash Flow from Investing Activities -9000 N/A N/A N/A 25000
Net Borrowings -1.55 million N/A N/A N/A N/A
Total Cash Flow from Financial Activities 767000 2.71 million 45.87 million N/A 3.04 million
Change to Operating Activities N/A N/A N/A N/A 902000
Change in Cash -3.66 million -10.99 million 18.46 million N/A -22.36 million
Total Cash from Operating Activities -4.42 million -13.69 million -27.39 million N/A -25.41 million
Depreciation 3.14 million 39000 39000 N/A 39000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities 44.7 million N/A N/A N/A N/A
Change to Net Income 2.7 million N/A N/A N/A 533000
Capital Expenditures 9000 N/A N/A N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 83.35 million N/A N/A 84.05 million 51.99 million
Total Stockholder Equity -50.56 million N/A N/A -41.74 million -26.24 million
Other Current Liabilities 3.71 million N/A N/A 28.31 million N/A
Total Assets 32.79 million N/A N/A 42.31 million 25.75 million
Common Stock 494000 -55903000 -48789000 N/A -26238000
Other Current Assets 6.96 million N/A N/A N/A N/A
Retained Earnings -286.93 million N/A N/A -251.02 million N/A
Other Liabilities 47.5 million 48.03 million 22.35 million N/A 44.36 million
Other Assets 18.28 million 17.7 million 19.44 million N/A 20.95 million
Cash 14.51 million N/A N/A 23.26 million 4.8 million
Total Current Liabilities 41.7 million N/A N/A 47.09 million N/A
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 421000 N/A N/A N/A N/A
Total Current Assets 21.47 million 8.57 million N/A 28.62 million 4.8 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets -50.56 million -55.9 million -48.79 million N/A -26.24 million
Short Term Investments N/A N/A N/A 1.21 million N/A
Long Term Debt 22.46 million N/A N/A 29.81 million 7.63 million
Inventory N/A N/A N/A N/A N/A
Accounts Payable 2.75 million N/A N/A 6.3 million N/A

Iterum Therapeutics plc (ITRM) Chart:

Iterum Therapeutics plc (ITRM) News:

Below you will find a list of latest news for Iterum Therapeutics plc (ITRM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Iterum Therapeutics plc (ITRM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Iterum Therapeutics plc (ITRM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320018337/0000899243-20-018337-index.htm
2018-05-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1659323/000000000018016477/0000000000-18-016477-index.htm
2019-07-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1659323/000000000019010990/0000000000-19-010990-index.htm
2020-06-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1659323/000000000020005048/0000000000-20-005048-index.htm
2020-07-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1659323/000000000020006781/0000000000-20-006781-index.htm
2020-08-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1659323/000000000020007309/0000000000-20-007309-index.htm
2020-08-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1659323/000000000020007843/0000000000-20-007843-index.htm
2020-09-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1659323/000000000020009107/0000000000-20-009107-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319003969/0000899243-19-003969-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319003970/0000899243-19-003970-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319003972/0000899243-19-003972-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319015011/0000899243-19-015011-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319015012/0000899243-19-015012-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319015013/0000899243-19-015013-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319015014/0000899243-19-015014-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319015015/0000899243-19-015015-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319015017/0000899243-19-015017-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319017199/0000899243-19-017199-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319017200/0000899243-19-017200-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319017201/0000899243-19-017201-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319017203/0000899243-19-017203-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319017204/0000899243-19-017204-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319017206/0000899243-19-017206-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924319017209/0000899243-19-017209-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320001838/0000899243-20-001838-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320001840/0000899243-20-001840-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320001844/0000899243-20-001844-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320001845/0000899243-20-001845-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320001846/0000899243-20-001846-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320001847/0000899243-20-001847-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320001851/0000899243-20-001851-index.htm
2020-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320010628/0000899243-20-010628-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320016405/0000899243-20-016405-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320016644/0000899243-20-016644-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320018267/0000899243-20-018267-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320018337/0000899243-20-018337-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320018404/0000899243-20-018404-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320027008/0000899243-20-027008-index.htm
2020-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000089924320029501/0000899243-20-029501-index.htm
2020-06-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1659323/000091957420004100/0000919574-20-004100-index.htm
2020-07-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1659323/000091957420004566/0000919574-20-004566-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000101297520000050/0001012975-20-000050-index.htm
2018-06-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000106299318002521/0001062993-18-002521-index.htm
2020-01-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000106299320000379/0001062993-20-000379-index.htm
2020-01-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000107261320000015/0001072613-20-000015-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000110465920006401/0001104659-20-006401-index.htm
2020-01-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000110465920006887/0001104659-20-006887-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000110465920069570/0001104659-20-069570-index.htm
2020-06-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000110465920070361/0001104659-20-070361-index.htm
2018-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000114420418031803/0001144204-18-031803-index.htm
2018-06-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000114420418033630/0001144204-18-033630-index.htm
2018-05-25POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1659323/000119312518173952/0001193125-18-173952-index.htm
2018-05-25424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1659323/000119312518175433/0001193125-18-175433-index.htm
2018-05-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1659323/000119312518175451/0001193125-18-175451-index.htm
2018-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000119312518178562/0001193125-18-178562-index.htm
2018-06-08SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000119312518188052/0001193125-18-188052-index.htm
2018-06-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000119312518189431/0001193125-18-189431-index.htm
2018-06-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000119312518189572/0001193125-18-189572-index.htm
2018-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000119312518247842/0001193125-18-247842-index.htm
2018-10-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000119312518303219/0001193125-18-303219-index.htm
2018-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000119312518326123/0001193125-18-326123-index.htm
2018-12-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1659323/000119312518356779/0001193125-18-356779-index.htm
2019-02-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1659323/000119312519029164/0001193125-19-029164-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000119312519084288/0001193125-19-084288-index.htm
2019-03-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1659323/000119312519085409/0001193125-19-085409-index.htm
2019-07-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1659323/000119312519193222/0001193125-19-193222-index.htm
2020-01-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000119312520009454/0001193125-20-009454-index.htm
2020-01-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000119312520015416/0001193125-20-015416-index.htm
2020-01-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000119312520015497/0001193125-20-015497-index.htm
2020-03-20S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1659323/000119312520080783/0001193125-20-080783-index.htm
2020-04-09S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1659323/000119312520102698/0001193125-20-102698-index.htm
2020-04-30S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1659323/000119312520128996/0001193125-20-128996-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000119312520158937/0001193125-20-158937-index.htm
2020-06-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1659323/000119312520160242/0001193125-20-160242-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000119312520160848/0001193125-20-160848-index.htm
2020-06-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1659323/000119312520160851/0001193125-20-160851-index.htm
2020-06-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000119312520162253/0001193125-20-162253-index.htm
2020-06-16SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000119312520170074/0001193125-20-170074-index.htm
2020-07-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1659323/000119312520184370/0001193125-20-184370-index.htm
2020-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000119312520184372/0001193125-20-184372-index.htm
2020-07-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1659323/000119312520186957/0001193125-20-186957-index.htm
2020-07-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000119312520187735/0001193125-20-187735-index.htm
2020-08-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1659323/000119312520211356/0001193125-20-211356-index.htm
2020-08-0610-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1659323/000119312520211364/0001193125-20-211364-index.htm
2020-08-0610-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1659323/000119312520211366/0001193125-20-211366-index.htm
2020-08-06S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1659323/000119312520212107/0001193125-20-212107-index.htm
2020-08-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1659323/000119312520212112/0001193125-20-212112-index.htm
2020-08-11424B1Prospectus [Rule 424(b)(1)]https://www.sec.gov/Archives/edgar/data/1659323/000119312520215705/0001193125-20-215705-index.htm
2020-08-13S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1659323/000119312520219169/0001193125-20-219169-index.htm
2020-08-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1659323/000119312520228339/0001193125-20-228339-index.htm
2020-08-27424B1Prospectus [Rule 424(b)(1)]https://www.sec.gov/Archives/edgar/data/1659323/000119312520232122/0001193125-20-232122-index.htm
2020-09-22S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1659323/000119312520250397/0001193125-20-250397-index.htm
2020-10-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1659323/000119312520263386/0001193125-20-263386-index.htm
2020-10-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1659323/000119312520263395/0001193125-20-263395-index.htm
2020-10-07424B1Prospectus [Rule 424(b)(1)]https://www.sec.gov/Archives/edgar/data/1659323/000119312520265100/0001193125-20-265100-index.htm
2020-10-09S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1659323/000119312520267344/0001193125-20-267344-index.htm
2020-10-21S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1659323/000119312520273093/0001193125-20-273093-index.htm
2020-10-22S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1659323/000119312520274059/0001193125-20-274059-index.htm
2020-10-22S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1659323/000119312520274638/0001193125-20-274638-index.htm
2020-10-26424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1659323/000119312520277136/0001193125-20-277136-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000119312520278634/0001193125-20-278634-index.htm
2020-10-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1659323/000119312520280757/0001193125-20-280757-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033874/0001209191-18-033874-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033877/0001209191-18-033877-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033879/0001209191-18-033879-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033891/0001209191-18-033891-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033894/0001209191-18-033894-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033895/0001209191-18-033895-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033896/0001209191-18-033896-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033897/0001209191-18-033897-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033903/0001209191-18-033903-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033905/0001209191-18-033905-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033907/0001209191-18-033907-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118033908/0001209191-18-033908-index.htm
2018-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034168/0001209191-18-034168-index.htm
2018-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034172/0001209191-18-034172-index.htm
2018-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034193/0001209191-18-034193-index.htm
2018-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034197/0001209191-18-034197-index.htm
2018-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034200/0001209191-18-034200-index.htm
2018-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034201/0001209191-18-034201-index.htm
2018-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034203/0001209191-18-034203-index.htm
2018-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034204/0001209191-18-034204-index.htm
2018-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034208/0001209191-18-034208-index.htm
2018-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034209/0001209191-18-034209-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034403/0001209191-18-034403-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034404/0001209191-18-034404-index.htm
2018-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118034622/0001209191-18-034622-index.htm
2018-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118047711/0001209191-18-047711-index.htm
2018-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118048518/0001209191-18-048518-index.htm
2018-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118048708/0001209191-18-048708-index.htm
2018-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118049884/0001209191-18-049884-index.htm
2018-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118056808/0001209191-18-056808-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000120919118060998/0001209191-18-060998-index.htm
2020-11-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1659323/000121390020034376/0001213900-20-034376-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1659323/000156459018021575/0001564590-18-021575-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1659323/000156459018029420/0001564590-18-029420-index.htm
2019-03-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1659323/000156459019009089/0001564590-19-009089-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1659323/000156459019013037/0001564590-19-013037-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1659323/000156459019013071/0001564590-19-013071-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459019018965/0001564590-19-018965-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1659323/000156459019018968/0001564590-19-018968-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459019022668/0001564590-19-022668-index.htm
2019-07-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1659323/000156459019024599/0001564590-19-024599-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459019031953/0001564590-19-031953-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1659323/000156459019031958/0001564590-19-031958-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459019042991/0001564590-19-042991-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1659323/000156459019043010/0001564590-19-043010-index.htm
2020-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020004834/0001564590-20-004834-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020009200/0001564590-20-009200-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020010241/0001564590-20-010241-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1659323/000156459020010242/0001564590-20-010242-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1659323/000156459020011162/0001564590-20-011162-index.htm
2020-04-27PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1659323/000156459020018836/0001564590-20-018836-index.htm
2020-05-07DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1659323/000156459020023000/0001564590-20-023000-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020025249/0001564590-20-025249-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1659323/000156459020025261/0001564590-20-025261-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020025814/0001564590-20-025814-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020029381/0001564590-20-029381-index.htm
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020030909/0001564590-20-030909-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020032262/0001564590-20-032262-index.htm
2020-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020032605/0001564590-20-032605-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020037224/0001564590-20-037224-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1659323/000156459020037240/0001564590-20-037240-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020039127/0001564590-20-039127-index.htm
2020-08-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1659323/000156459020040029/0001564590-20-040029-index.htm
2020-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020042192/0001564590-20-042192-index.htm
2020-09-028-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020042249/0001564590-20-042249-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020044659/0001564590-20-044659-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1659323/000156459020045315/0001564590-20-045315-index.htm
2020-01-31DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000165932320000001/0001659323-20-000001-index.htm
2020-06-12DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000165932320000002/0001659323-20-000002-index.htm
2020-07-07DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1659323/000165932320000003/0001659323-20-000003-index.htm
2019-07-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1659323/999999999519001619/9999999995-19-001619-index.htm
2020-08-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1659323/999999999520002086/9999999995-20-002086-index.htm
2020-08-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1659323/999999999520002266/9999999995-20-002266-index.htm
2020-10-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1659323/999999999520002761/9999999995-20-002761-index.htm
2020-10-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1659323/999999999520002955/9999999995-20-002955-index.htm
2018-05-25CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1659323/999999999718005859/9999999997-18-005859-index.htm

Iterum Therapeutics plc (ITRM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Iterum Therapeutics plc (ITRM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 115%
Institutional Ownership: 3421%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-09-30Judith M. MatthewsChief Financial OfficerSell56,130.001.6492,053.200.00https://www.sec.gov/Archives/edgar/data/1659323/000089924320027008/0000899243-20-027008-index.htm
2018-05-30Mark ChinDirectorBuy337,606.0013.004,388,878.001,031,903.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034622/0001209191-18-034622-index.htm
2018-05-30RONALD HUNTDirectorBuy278,062.0013.003,614,806.001,071,688.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034403/0001209191-18-034403-index.htm
2018-05-30Vijay K Lathi10% Share HolderBuy278,062.0013.003,614,806.001,071,688.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034404/0001209191-18-034404-index.htm
2018-10-30Mark ChinDirectorBuy58,000.006.10353,800.001,089,903.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118056808/0001209191-18-056808-index.htm
2020-07-01Mark ChinDirectorBuy5,703.0011,857.00https://www.sec.gov/Archives/edgar/data/1659323/000089924320018267/0000899243-20-018267-index.htm
2018-05-30Patrick J HeronDirectorBuy354,949.0013.004,614,337.001,197,161.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034197/0001209191-18-034197-index.htm
2020-06-02Sofinnova Venture Partners IX, L.P.10% Share HolderSell400,000.001.61642,960.001,226,514.00https://www.sec.gov/Archives/edgar/data/1659323/000110465920069570/0001104659-20-069570-index.htm
2018-05-30Michael W. DunneChief Scientific OfficerBuy2,000.0013.0026,000.00146,458.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034172/0001209191-18-034172-index.htm
2018-08-24Michael W. DunneChief Scientific OfficerBuy500.0010.005,000.00146,958.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118048708/0001209191-18-048708-index.htm
2018-08-27Michael W. DunneChief Scientific OfficerBuy500.0010.005,000.00147,458.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118048708/0001209191-18-048708-index.htm
2018-09-04Michael W. DunneChief Scientific OfficerBuy500.0010.005,000.00147,958.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118049884/0001209191-18-049884-index.htm
2020-06-01Sofinnova Venture Partners IX, L.P.10% Share HolderSell100,000.001.69169,120.001,626,514.00https://www.sec.gov/Archives/edgar/data/1659323/000110465920069570/0001104659-20-069570-index.htm
2018-05-30JAMES HEALYDirectorBuy500,000.0013.006,500,000.001,726,514.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034209/0001209191-18-034209-index.htm
2018-05-30Sofinnova Venture Partners IX, L.P.10% Share HolderBuy500,000.0013.006,500,000.001,726,514.00https://www.sec.gov/Archives/edgar/data/1659323/000114420418031803/0001144204-18-031803-index.htm
2018-05-30Brenton Karl AhrensDirectorBuy506,656.0013.006,586,528.001,733,170.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034204/0001209191-18-034204-index.htm
2018-05-30X L.P. CANAANDirectorBuy506,656.0013.006,586,528.001,733,170.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034203/0001209191-18-034203-index.htm
2018-11-30David George KellyDirectorBuy10,000.006.2962,887.0019,548.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118060998/0001209191-18-060998-index.htm
2020-10-27Michael W. DunneChief Scientific OfficerBuy61,540.00209,498.00https://www.sec.gov/Archives/edgar/data/1659323/000089924320029501/0000899243-20-029501-index.htm
2018-05-30Corey N. FishmanPresident & CEOBuy3,000.0013.0039,000.00237,953.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034168/0001209191-18-034168-index.htm
2018-08-17Corey N. FishmanPresident & CEOBuy2,000.008.7317,465.60239,953.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118047711/0001209191-18-047711-index.htm
2018-08-23Paul R EdickDirectorBuy500.0010.445,218.7025,236.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118048518/0001209191-18-048518-index.htm
2019-05-24David George KellyDirectorBuy6,154.0025,702.00https://www.sec.gov/Archives/edgar/data/1659323/000089924319015011/0000899243-19-015011-index.htm
2018-05-30Shahzad MalikDirectorBuy8,144.0013.00105,872.0029,836.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034208/0001209191-18-034208-index.htm
2019-05-24Paul R EdickDirectorBuy6,154.0031,390.00https://www.sec.gov/Archives/edgar/data/1659323/000089924319015017/0000899243-19-015017-index.htm
2018-05-30Patrick J HeronDirectorBuy101,150.0013.001,314,950.00341,155.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034197/0001209191-18-034197-index.htm
2020-06-13David George KellyDirectorBuy11,406.0037,108.00https://www.sec.gov/Archives/edgar/data/1659323/000089924320016644/0000899243-20-016644-index.htm
2018-05-30RONALD HUNTDirectorBuy384,615.0013.004,999,995.00384,615.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034403/0001209191-18-034403-index.htm
2018-05-30Vijay K Lathi10% Share HolderBuy384,615.0013.004,999,995.00384,615.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034404/0001209191-18-034404-index.htm
2018-05-30Judith M. MatthewsChief Financial OfficerBuy4,000.0013.0052,000.0056,130.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034193/0001209191-18-034193-index.htm
2020-07-01RONALD HUNTDirectorBuy5,703.005,703.00https://www.sec.gov/Archives/edgar/data/1659323/000089924320018337/0000899243-20-018337-index.htm
2019-05-24Brenton Karl AhrensDirectorBuy6,154.006,154.00https://www.sec.gov/Archives/edgar/data/1659323/000089924319015012/0000899243-19-015012-index.htm
2019-05-24JAMES HEALYDirectorBuy6,154.006,154.00https://www.sec.gov/Archives/edgar/data/1659323/000089924319015015/0000899243-19-015015-index.htm
2019-05-24Mark ChinDirectorBuy6,154.006,154.00https://www.sec.gov/Archives/edgar/data/1659323/000089924319015014/0000899243-19-015014-index.htm
2019-05-24Patrick J HeronDirectorBuy6,154.006,154.00https://www.sec.gov/Archives/edgar/data/1659323/000089924319015013/0000899243-19-015013-index.htm
2018-05-30Shahzad MalikDirectorBuy228,840.0013.002,974,920.00838,325.00https://www.sec.gov/Archives/edgar/data/1659323/000120919118034208/0001209191-18-034208-index.htm
2020-07-01Patrick J HeronDirectorBuy2,852.009,006.00https://www.sec.gov/Archives/edgar/data/1659323/000089924320018404/0000899243-20-018404-index.htm